[1]
Aghabeigi, S., Farasatinasab, M., Amouzegar, A., Ramezaninejad, S., Ghanbari, B., Pakdaman, N., Motamed, M.R., Almasi, S., Rezaie, N., Nasiripour, S., Sabzghabaei, F. and Basi, A. 2019. Rituximab Utilization Evaluation with Focused on Available Evidence for Off-Labeled Indications. Journal of Pharmaceutical Care. 7, 1-2 (Aug. 2019), 14-20. DOI:https://doi.org/10.18502/jpc.v7i1-2.1617.